Cyclica receives CAD$2.4M to advance non-hormonal contraceptives
Cyclica has received a grant from the Bill & Melinda Gates Foundation to apply its AI-enabled drug discovery platform to new therapeutic options for multiple low-data biological targets. The end goal is to expand the range of accessible non-hormonal contraceptive choices for women in developing countries. … Read More